# Adductor Canal Block Versus Liposomal Bupivacaine in TKA

> **NCT04086186** · PHASE4 · COMPLETED · sponsor: **Good Samaritan Regional Medical Center, Oregon** · enrollment: 60 (actual)

## Conditions studied

- Total Knee Arthroplasty
- Post-operative Pain Control

## Interventions

- **PROCEDURE:** Liposomal Bupivacaine Peri-articular Injection
- **PROCEDURE:** Adductor canal block

## Key facts

- **NCT ID:** NCT04086186
- **Lead sponsor:** Good Samaritan Regional Medical Center, Oregon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-22
- **Primary completion:** 2018-11-25
- **Final completion:** 2018-12-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086186, "Adductor Canal Block Versus Liposomal Bupivacaine in TKA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04086186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*